1. Home
  2. SRPT

as 09-04-2025 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Founded: 1980 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 2.0B IPO Year: 1997
Target Price: $44.37 AVG Volume (30 days): 9.6M
Analyst Decision: Hold Number of Analysts: 30
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.60 EPS Growth: N/A
52 Week Low/High: $10.41 - $138.81 Next Earning Date: 08-06-2025
Revenue: $2,481,531,000 Revenue Growth: 64.89%
Revenue Growth (this year): 9.41% Revenue Growth (next year): -23.26%

SRPT Daily Stock ML Predictions

Share on Social Networks: